Companies: 10,795·Total market cap: $144.5T
MaxCyte, Inc.

MaxCyte, Inc.

MXCTNASDAQHealthcare● Active
$1.15
+$0.01(+0.88%)
Market Cap$123189923
P/E Ratio
52W High$2.38
52W Low$0.643
Overview

MaxCyte, Inc. (MXCT) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · MXCT · as of 2026-06-10

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$103.04M$154.48M$168.29M$227.34M$255.04M
Net Receivables$3.50M$4.68M$5.78M$11.18M$6.88M
Inventory$7.55M$8.91M$12.23M$8.58M$5.20M
Total Current Assets$118.37M$171.68M$190.19M$252.27M$270.43M
PP&E Net$28.45M$30.47M$34.75M$33.58M$13.37M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$0.65M$0.00M$0.00M$0.00M$0.00M
Total Assets$202.51M$239.47M$268.27M$286.65M$284.12M
Liabilities
Short-Term Debt$1.46M$0.86M$0.00M$0.00M$0.00M
Accounts Payable$1.40M$1.36M$0.74M$0.29M$1.82M
Total Current Liabilities$14.27M$15.78M$17.86M$15.43M$15.62M
Long-Term Debt$0.00M$0.00M$0.00M$0.00M$0.00M
Total Liabilities$31.02M$33.22M$36.11M$32.69M$21.22M
Stockholders Equity
Retained Earnings($261.48M)($216.85M)($175.80M)($137.88M)($114.30M)
Total Stockholders Equity$171.49M$206.25M$232.17M$253.97M$262.90M
Total Liab & Equity(computed)$202.51M$239.47M$268.27M$286.65M$284.12M
Debt Summary
Total Debt$17.94M$18.03M$18.74M$16.09M$5.68M
Net Debt($2.12M)($9.85M)($27.76M)$5.03M($42.10M)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M

Explore more MaxCyte, Inc. data

About MaxCyte, Inc. (MXCT) Balance Sheet

MaxCyte, Inc. (MXCT) balance sheet shows total assets of $0.20B with cash of $0.10B. Total liabilities are $0.03B, total debt $0.02B, and stockholders equity $0.17B.

Frequently asked questions

MXCT · 4 questions

MaxCyte, Inc. has total debt of $0.02B with net debt of ($0.00B).

MXCT total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10